by Cells4Life Middle East | Feb 22, 2017 | Stem Cell News
New research published in the journal Blood describes how a hormone called erythropoietin may be useful for improving the success rate of cord blood transplants. The research paper indicates that erythropoietin (EPO) may be able to improve the survival rate for...
by Cells4Life Middle East | Feb 19, 2017 | Stem Cell News
A young 4-year-old boy named Lincoln Honoway has survived a life-threatening form of anaemia, thanks to a stem cell transplant. Lincoln was diagnosed with a condition called aplastic anaemia when he was just an infant. This condition prevents the body from...
by Cells4Life Middle East | Feb 17, 2017 | Stem Cell News
Dr. Omar Aljitawi, an associate professor of Hematology/Oncology from the Wilmot Cancer Institute recently conducted a small clinical trial using cord blood as cancer therapy. It was the first human trial of its kind and its findings may lead to a dramatic...
by Cells4Life Middle East | Feb 15, 2017 | Stem Cell News
According to the World Health Organisation, congestive heart failure kills more than 17 million people per year globally. Congestive heart failure occurs when the heart does not pump blood as well as it should. A range of conditions can cause congestive...
by Cells4Life Middle East | Feb 12, 2017 | Stem Cell News
Researchers have discovered a new way to repair a gene defect in stem cells from a rare immunodeficiency. The immunodeficiency disorder is called X-linked chronic granulomatous disease (X-CGD). The disease causes the immune system to malfunction and leaves...
by Cells4Life Middle East | Feb 10, 2017 | Stem Cell News
Scientists have long suspected that stem cells could restore vision in mammals. Researchers in Japan have confirmed that is the case thanks to a recent stem cell trial. They have managed to successfully restore vision in mice with end-stage eye disease — a...
